Official Journal of Research Center for Gastroenterology and Liver Diseases
Scopus by Title (Ref)
Articles that cite the referenced work, matched by title from the Scopus database.
Changes in the distribution pattern of hepatitis c virus genotypes among chronic hepatitis patients: A cross-sectional study
Clinical Laboratory
August 2021
Kazemi R.
The predictive factors for favorable outcomes of peginterferon and ribavirin combination therapy in HCV-infected patients
Acta Medica Iranica
2020
Moayedi J.
Naturally occurring NS5A and NS5B resistant associated substitutions in HCV and HCV/HIV patients in iranian population
Clinics and Research in Hepatology and Gastroenterology
October 2019
Ramezani A.
The role of hepatic progenitor cells in predicting response to therapy in Egyptian patients with chronic hepatitis C, genotype 4
African Health Sciences
March 2019
Helal T.E.A.
Open Access
Psychiatric side effects of pegylated interferon-α and ribavirin therapy in iranian patients with chronic hepatitis c: A meta-analysis
Experimental and Therapeutic Medicine
August 2018
Davoodi L.
Open Access
The evaluation of interferon lambda 4 rs368234815 as a predictor factor in treated patients with chronic hepatitis C genotype 1a infection
Indian Journal of Medical Microbiology
April-June 2017
Jalilian S.
Open Access
IL28B rs12980275 and HLA rs4273729 genotypes as a powerful predictor factor for rapid, early, and sustained virologic response in patients with chronic hepatitis C
Archives of Virology
1 January 2017
Sedighimehr P.
Risk factors for migraine attacks in patients undergoing treatment for hepatitis C
Iranian Red Crescent Medical Journal
January 2017
Salesi R.
Recommendations for the clinical management of hepatitis C in Iran: A consensus-based national guideline
Hepatitis Monthly
August 2016
Alavian S.M.
Open Access
Prevalence of hepatitis C virus genotypes among patients in countries of the eastern mediterranean regional office of WHO (EMRO): A systematic review and meta-analysis
Hepatitis Monthly
19 April 2016
Sadeghi F.
Open Access
Hepatitis C therapy-related haematological side effects are associated with treatment outcome
Serbian Journal of Experimental and Clinical Research
March 2016
Vukovic V.R.
Open Access
Epidemiology of hepatitis C virus in Iran
World Journal of Gastroenterology
14 October 2015
Taherkhani R.
Open Access
Efficacy and tolerability of peginterferon alpha-2a and peginterferon alpha-2b in Iranian patients with chronic hepatitis C
Hepatitis Monthly
29 September 2015
Pouresmaeeli M.
Open Access
Interferon-λpolymorphisms and response to pegylated interferon in Iranian hepatitis C patients
World Journal of Gastroenterology
7 August 2015
Haj-sheykholeslami A.
Open Access
High resolution melting curve assay for detecting rs12979860 IL28B polymorphisms involved in response of iranian patients to chronic hepatitis C treatment
Asian Pacific Journal of Cancer Prevention
2015
Fateh A.
Open Access
Mutations in the NS5A gene of hepatitis C virus subtype 1b and response to peg-IFNα-2a/RBV combination therapy in Azerbaijani patients
Archives of Virology
17 October 2014
Bokharaei-Salim F.
Predicting the outcomes of combination therapy in patients with chronic hepatitis c using artificial neural network
Hepatitis Monthly
1 June 2014
Aval F.S.
Open Access
Associations between human TRIM22 gene expression and the response to combination therapy with Peg-IFNα-2a and ribavirin in Iranian patients with chronic hepatitis C
Journal of Medical Virology
September 2014
Sadeghi F.
Interleukin-28b (rs12979860) gene variation and treatment outcome after peginterferon plus ribavirin therapy in patients with genotype 1 of hepatitis C virus
Journal of Research in Medical Sciences
2014
Kalantari H.
Evaluated outcomes in patients with chronic hepatitis C
Gastroenterology and Hepatology from Bed to Bench
2013
Ashtari S.
Hepatitis C and why the treatment is needed now? The summary report from the cross-border symposium of the 5th Tehran Hepatitis Congress May 2013
Hepatitis Monthly
20 November 2013
Ebrahimi Daryani N.
Open Access
Plasma zinc level in hepatitis C patients with or without beta thalassemia major; Is there any difference?
Hepatitis Monthly
12 August 2013
Abbasinazari M.
Open Access
Some considerations about cardiac toxicity of combination therapy for chronic hepatitis C
Hepatitis Monthly
May 2013
Karbasi-Afshar R.
Open Access
Adherence to chronic hepatitis C treatment regimen: First report from a referral center in Iran
Hepatitis Monthly
June 2013
Ravi S.
Open Access